Podcasts about Inner Workings

On this episode of Inner Workings, Justin Drake, Director, Internal Communications, speaks with Allyson Lovejoy, Business Development Director, and Lexi Naetzker, Recruiter, to learn more about our business development team. Listen to the episode to understand what a day in the life of a business development associate is like, what traits and skills are key for success in a business development role and what makes these roles so important to Gartner's business.    Does Gartner's Business Development team sound like the right fit for you? If so, learn more about the team and explore opportunities to join us here. 

To anticipate threat actors' behavior, we must understand them. That's why CrowdStrike closely tracks the evolution and activity of 257 named adversaries, including the eCrime actor LUNAR SPIDER. “They almost behave like a startup; they're constantly testing and innovating and developing what they're doing,” Adam says of the group. “It's an interesting paradigm when you think about how these eCrime actors operate.” In this episode, Adam and Cristian take a deep dive into the inner workings of LUNAR SPIDER, discussing their role in the complex eCrime ecosystem, their collaboration with other adversaries, and the evolution of their techniques, including changes to the BokBot/IcedID malware over time and their eventual transition to the Lotus loader. Tune in to learn what defenders should know about this threat actor's behavior and how to defend against their evolving activity. Learn more about the eCrime ecosystem in this infographic.

Muthu Muthiah is the CIO at Children's Healthcare of Atlanta (CHOA), one of the largest pediatric care providers in the United States. At CHOA, Muthiah leads the investment office, which manages the system's long-term $6.4 billion investment portfolio. Previously Muthu has been in several allocator roles at different types of institutional pools of capital.Links: ⭐ Sponsored by Podcast10x - Podcasting agency for VCs - https://podcast10x.comCHOA's website - https://choa.org/Muthu Muthiah on LinkedIn - https://www.linkedin.com/in/muthumuthiah/

In this episode of 'The Coaching 101 Podcast,' hosts Daniel Chamberlain, Kenny Simpson, and guest Stewart Brooking discuss the expansive resources available for learning football strategy and coaching techniques. They explore various avenues such as social media, podcasts, clinics, and books. Brooking shares his journey from a broadcasting major to a football coach and podcaster, detailing how he uses his podcast to learn from experienced coaches and challenge his own beliefs. The conversation highlights the importance of practical experience, the need for continuous learning, and balancing theoretical knowledge with on-field application.00:00 Introduction and Guest Introduction00:46 Coach Stewart's Podcast Journey01:53 The Value of Podcasting for Coaches04:28 Clinic Season and Learning Opportunities06:56 Quote of the Week and Team Themes09:01 Simplifying Football for Players and Coaches10:15 Learning Football: Resources and Strategies16:07 The Inner Workings of Podcasting30:18 Finding and Booking Podcast Guests31:28 Dealing with Intimidation in Coaching Circles33:11 The Importance of Delegation34:45 Balancing Learning and Experience in Coaching37:28 Navigating the Sea of Football Knowledge40:17 The Value of Conceptual Understanding in Football53:31 What Not to Do as a Coach55:34 Wrapping Up and Final Thoughts

The investigators begin searching the exterior of the standpipe.  The evidence they find incentivizes further exploration... inside the facility proper... To support us please had over to: https://ko-fi.com/twistedgearsstudios Visit our Shop: https://www.twistedgearsstudios.com/shop For more on all we have going on please visit: https://www.twistedgearsstudios.com  Instagram: https://www.instagram.com/thetwistedgear/ Facebook: https://www.facebook.com/TheTwistedGear Tik-Tok: https://www.tiktok.com/@twistedgearsstudios #TheTwistedGear, #tabletop, #ymm, #ymmarts, #ymmgeek, #tabletoprpg, #rpg, #rpggame, #callofcthulhu, #callofcthulhurpg, #cthulhu

P. Pu. Pankajbhai is a man on a noble mission. His single-minded effort lies in spreading his understanding and technique of finding happiness within, armed with the lessons of many great masters. He has been a scientist and his search for finding the meaning of life has led to the answers he kindly shares with many. He intends to reach all the people regardless of age, sex, social strata and help them lead a happier and meaningful existence. Dig deeper into his methods and guidance by logging on to his website here:www.paramsukhonlinegurukul.comThis talk in Hindi is almost like a discourse and will help you understand his teachings - I have simply asked a couple of relevant questions and he has been evocative in sharing detailed answers. May all benefit from our intent to serve.For the video, please check www.youtube.com/c/thevaluesworkshop

Grey Dynamics welcomes John Lechner to the podcast. He is a journalist and researcher, focusing on security issues with a heavy approach to on-the-ground coverage. John is also an expert on Russia's growing influence in Africa. He speaks fluent Russian; advanced French, Turkish, and Georgian; and conversational Bosnian-Croatian-Serbian (BCS), Chechen, German, and Sango.You can find his articles published in Foreign Policy, War on the Rocks, Kyiv Post, The Diplomat, Africa is a Country, African Arguments, The National Interest, and Defense One, among others. Additionally, his book on the inner workings of the Wagner Group is for sale on AmazonFind John LechnerLinkedInJohn Lechner AuthorDeath Is Our Business: Russian Mercenaries and the New Era of Private WarfareRelated Links:Wagner PMC Activity in the Central African Republic: A Geospatial AnalysisPMC Wagner in Africa: ForecastAdvance Your Intelligence Career Today!We are the first fully online intelligence school helping professionals to achieve their long term goals. Our school with tons of new material is currently under construction and will be out there very soon. Meanwhile, you can sign up and be the first to know when we launch, plus get exclusive tips and offers.Get access to exclusive Grey Dynamics ReportsWith security clearance, you can take a crucial role in our intelligence community. As a cleared member, you get access to Secret & Top Secret grade publications. If you are a Top Secret holder, you also get access to our community area, where you can interact with other members and with our analysts! Subscribe today!The Grey Dynamics Podcast is available on all major platforms!YouTubeSpotifyApple PodcastGoogle PodcastAmazon Podcast Hosted on Acast. See acast.com/privacy for more information.

Mart Green joins the podcast to share how his retail book chain stayed profitable and growing in the face of the rise of Amazon, defying the odds. Plus, Mart explains Hobby Lobby's Green Family's inner workings and how he navigated the critical reaction to the He Gets Us campaign.

Subscribe To The Willie D Live Audio Podcast at:https://podcasters.spotify.com/pod/show/williedlivepodcastArtistActivist InvestorPodcasterSupport This ChannelCashApp http://cash.app/$williedlive PayPal http://www.paypal.me/williedlive Support My Foundationhttps://marvelousbridge.orgFollow me on Social Media:Instagram: williedliveTwitter: williedliveTikTok: williedliveFacebook: williedofficial

This week Ari sits down with Liz Pelly, a prominent music journalist and author of the new book Mood Machine: The Rise of Spotify and the Costs of the Perfect Playlist. Liz's journalism has appeared in NPR, The Guardian, and Pitchfork among other prestigious publications. Preceded by an exposé in Harper's Magazine, Pelly's latest work, Mood Machine, pulls back the curtain on Spotify's exploitative practices and uncovers how those practices impact artists and listeners. In this episode, Liz gives the low down on research she conducted for the book and explains how Spotify has unfairly conspired with major labels since its launch. As she does in Mood Machine, Liz calls out Spotify's Perfect Fit Content (PFC) program and explains how its use of ghost artists degrades the integrity of their model for all. Ari and Liz discuss the value of music and how that can differ in the eyes of major corporations and individuals. Whether you're an artist, label, or listener who uses Spotify, this episode will help you understand the impact Spotify's model has on your relationship to music.https://www.instagram.com/lizpelly Harper's article: https://harpers.org/archive/2025/01/the-ghosts-in-the-machine-liz-pelly-spotify-musicians/Chapters00:00 The Inner Workings of Spotify12:48 Ghost Artists and the PFC Program37:50 Spotify's Launch and Major Label Relationships41:26 The Evolution of Streaming Contracts44:14 Valuing Music: A Cultural Perspective49:43 The Impact of Streaming on Music Value56:10 Algorithms and the Personalization of Music01:01:20 The Role of Music in Society01:07:23 Future Solutions for Musicians01:19:38 Defining Success in the New Music BusinessEdited and mixed by Ari DavidsMusic by Brassroots DistrictProduced by the team at Ari's TakeOrder the THIRD EDITION of How to Make It in the New Music Business: https://book.aristake.com Hosted on Acast. See acast.com/privacy for more information.

Ever wondered what goes into the professional production of a fitness video? Tune into episode 62 where Ellen de Werd interviews her entire cast immediately after filming a lesson. We talk openly, honestly, and candidly about the whole process, which takes eight weeks from start to finish. This episode is highly entertaining, so grab some popcorn 

Hour 1: The Tara Show - “The Reality of Trans Ideology” “How the Dems have Allowed Terroism” “The Inner-Workings of the Censorship Machine” “The Purpose of DOGE” full 1931 Fri, 07 Feb 2025 15:23:00 +0000 ktArmtRdKIpLAnthzIGoVHcbEr2pfad4 news The Tara Show news Hour 1: The Tara Show - “The Reality of Trans Ideology” “How the Dems have Allowed Terroism” “The Inner-Workings of the Censorship Machine” “The Purpose of DOGE” Tara presides over the Upstate's #1 all news/talk morning show every weekday on News/Talk 989 WORD.Tara's faithful listeners are affectionately known as "Tara-ists" because of their passion and participation in the show. Tara was named 2021 Best News Talk Show and Best overall Personality, AGAIN, by the South Carolina Broadcasters Association! Tara took home the same honors in 2018 and was also named 2016 "Personality of the Year!" In addition, Tara has also won over two dozen state and national journalism awards for column writing, news reporting and investigative reporting while working for three newspapers and writing for a variety of national publications. She won a first place reporting award from the North Carolina Press Association for an investigative series about the weaknesses in Charlotte's overburdened court system, which regularly let murderers off the hook with less than 15 years in prison. Due to her work, that system has been reformed. Tara is also a winner of the prestigious first place Green Eyeshade Award, a national award for column writing from The Society of Professional Journalists. Tara took to the airwaves about 15 years ago to do a radio show heard up and down the coast and fell in love with bypassing her editors to talk straight to the people. Tara hasn't stopped reporting, and still brings her investigative journalism to the show. Tara is a mom, wife and talk radio convert-- and weekday mornings she's live and local on News/Talk 989 WORD. Are you a "Tara-ist"? It's time to get captured!      2024 © 2021 Audacy, Inc. News False https://player.amperwavepodcasting.com?feed-link=https%3A%2F%

How Zaha Hadid's Visionary Design Philosophy is Shaping the Future of Architecture and Innovation In today's episode of speaking real estate podcast, we had Mr. Patrick Schumacher, the principal architect at Zaha Hadid Architech, who shares valuable insights on the firm's unique approach to design, the evolution of architecture, and the impact of emerging technologies in shaping the future of the industry. Here's what we discussed: - The role and importance of architectural competitions in defining the trajectory of a designer's career - A closer look at three major, game-changing projects that have become benchmarks for innovative architecture - What parametric design is, and how it's transforming architecture designs and , adaptable structures - The importance of collaboration and socialization within the firm to drive creativity and problem-solving - Key factors that contribute to losing a project and how these lessons have helped the firm grow Don't miss this in-depth conversation about the future of architecture, the importance of visionary leadership, and how technology is reshaping the design world. Timestamps: 00:00 Trailer 00:54 - Introduction 01:58 - Motivation for Joining Zaha Hadid 04:06 - Early Lessons from Zaha Hadid 05:23 - Insights on Architectural Competitions 09:28 - Three Key Projects 12:04 - Inner Workings of the Firm 14:35 - Vision and Direction for the Studio 21:59 - Advice for Other Design Studios 26:55 - What is Parametric Design in Architecture? 37:58 - Adapting to Change in the Industry 49:36 - Patrick's Design Theory 56:28 - Thoughts on Socialization 57:07 - The Cluster Scheme Concept 58:08 - Real Estate Trends in China 01:05:56 - The Role of New Technologies 01:08:59 - The Metaverse in Architecture 01:14:59 - Reflections on Three Decades of Experience 01:17:26 - Major Factors Behind Losing a Project 01:20:02 - Favorite Project to Work On 01:20:16 - Final Thoughts and Conclusion Guest: Mr. Patrik Schumacher Principal architect at Zaha Hadid Architects Instagram: https://www.instagram.com/schumacher.patrik/

At Gartner, we offer a lifetime of opportunities driven by our growth. With so many possibilities across the company, it can be hard to know where you may fit within the organization. In this episode of Inner Workings, we're sitting down with two associates to learn more about the differences and similarities between their roles in the Client Success organization and the Research & Advisory world. Tune in to hear from Hannah Decker, Director Analyst, and Alexandru Nastasa, Client Success Associate, as they share what they do, how they help our clients, what makes a great profile for their role, and why you might want to join their teams at Gartner. 

Daily News: https://www.polnewscentral.com/ --- Live show 8PM EST: https://odysee.com/@PNNAmerica:a/PNNAmericaJan --- Help by supporting the show: Bitcoin: bc1q775yrp0az9e88yp3nzg0a5p7nzgex0m7e8xcdk Dogecoin: DS1Fp4wmQ1jdbYj4cqi3MJNWmzYe6tt9w4 Monero: 8BaVtQCDnQhY1Wc3twwx2NCPumhTTVCweZRQT2X7V3D9gfEUCWt6U79izJp2qiDYx3cAjPjQFEWxFbKyLoTTWSRzGC27Tdk --- MY Website! (Book included): https://www.pnnamerica.com ---

Send us a textUncover the power of courage and choice in our latest podcast episode featuring inspiring stories from Garrett Gravesen, Eric Hinman, and Marcus Kaulius. Garrett shares the concept of "10 seconds of insane courage," a mantra that has propelled him to overcome self-doubt and embrace life-changing opportunities. His journey, along with insights from Ironman Eric Hinman and author Marcus Kaulius, illustrates how boldness and mindset shifts can open doors and lead to unexpected victories. Through their experiences, you'll learn how embracing courage can transform you from an underdog to a trailblazer.Eric Hinman brings his expertise in lifestyle design, emphasizing the need to surround oneself with enriching people and experiences. Meanwhile, Marcus Kaulius, author of "Play a Bigger Game," delves into the power of choice, highlighting how maintaining a positive outlook amid adversity can lead to incredible personal growth. Their stories are complemented by a compelling tale of ambition and resilience, where sheer determination and courage lead to career breakthroughs despite the odds. These narratives remind us that courage, coupled with intentional decision-making, can pave the way to success. This episode provides inspiration and actionable strategies for anyone looking to enrich their personal and professional life through the power of choice and courage.Thank you for tuning in! If you feel led, please subscribe & share the show to others who you believe would benefit from it.Keep in touch below! MAGIC MIND - The World's First Mental Performance Shot - 20% Off Join The Unshakeable Discipline Community! LinkedIn | www.linkedin.com/in/ryanacass/ Instagram | @ryanacass

American healthcare is well known for its extreme cost and worst outcomes among industrialized (such as the 38 OECD member) countries, and beyond that to be remarkably opaque. The high cost of prescription drugs contributes, and little has been done to change that except for the government passing the Affordable Insulin Now Act at the end of 2022, enacted in 2023. But in January 2022 Mark Cuban launched Cost Plus Drugs that has transformed how many Americans can get their prescriptions filled at a fraction of the prevailing prices, bypassing pharmacy benefit managers (PBMs) that control 80% of US prescriptions. That was just the beginning of a path of creative destruction (disruptive innovation, after Schumpeter) of many key components American healthcare that Cuban is leading, with Cost Plus Marketplace, Cost Plus Wellness and much more to come. He certainly qualifies as a master disrupter: “someone who is a leader in innovation and is not afraid to challenge the status quo.” Below is a video clip from our conversation dealing with insurance companies. Full videos of all Ground Truths podcasts can be seen on YouTube here. The current one is here. If you like the YouTube format, please subscribe! The audios are also available on Apple and Spotify.Transcript with External links to Audio (00:07):Hello, it's Eric Topol with Ground Truths, and I have our special phenomenal guest today, Mark Cuban, who I think you know him from his tech world contributions and Dallas Mavericks, and the last few years he's been shaking up healthcare with Cost Plus Drugs. So Mark, welcome.Mark Cuban (00:25):Thanks for having me, Eric.Eric Topol (00:27):Yeah, I mean, what you're doing, you've become a hero to millions of Americans getting them their medications at a fraction of the cost they're used to. And you are really challenging the PBM industry, which I've delved into more than ever, just in prep for our conversation. It's just amazing what this group of companies, namely the three big three CVS Caremark, Optum of UnitedHealth and Express Scripts of Cigna with a market of almost $600 billion this year, what they're doing, how can they get away with all this stuff?Inner Workings of Pharmacy Benefit ManagersMark Cuban (01:03):I mean, they're just doing business. I really don't blame them. I blame the people who contract with them. All the companies, particularly the bigger companies, the self-insured companies, where the CEO really doesn't have an understanding of their healthcare or pharmacy benefits. And so, the big PBMs paid them rebates, which they think is great if you're a CEO, when in reality it's really just a loan against the money spent by your sickest employees, and they just don't understand that. So a big part of my time these days is going to CEOs and sitting with them and explaining to them that you're getting ripped off on both your pharmacy and your healthcare side.Eric Topol (01:47):Yeah, it's amazing to me the many ways that they get away with this. I mean, they make companies sign NDAs. They're addicted to rebates. They have all sorts of ways a channel of funds to themselves. I mean, all the things you could think of whereby they even have these GPOs. Each of these companies has a group purchasing organization (I summarized in the Table below).Mark Cuban (02:12):Yeah, which gives them, it's crazy because with those GPOs. The GPO does the deal with the pharmacy manufacturer. Then the GPO also does the deal with the PBM, and then the PBM goes to the self-insured employer in particular and says, hey, we're going to pass through all the rebates. But what they don't say is they've already skimmed off 5%, 10%, 20% or more off the top through their GPO. But that's not even the worst of it. That's just money, right? I mean, that's important, but I mean, even the biggest companies rarely own their own claims data.Mark Cuban (02:45):Now think about what that means. It means you can't get smarter about the wellness of your employees and their families. You want to figure out the best way to do GLP-1s and figure out how to reduce diabetes, whatever it may be. You don't have that claims data. And then they don't allow the companies to control their own formularies. So we've seen Humira biosimilars come out and the big PBMs have done their own version of the biosimilar where we have a product called Yusimry, which is only $594 a month, which is cheaper than the cheapest biosimilar that the big three are selling. And so, you would think in a normal relationship, they would want to bring on this new product to help the employer. No, they won't do it. If the employer asks, can I just add Cost Plus Drugs to my network? They'll say no, every single time.Mark Cuban (03:45):Their job is not to save the employer money, particularly after they've given a rebate. Because once they give that loan, that rebate to the employer, they need to get that money back. It's not a gift. It's a loan and they need to have the rebates, and we don't do rebates with them at all. And I can go down the list. They don't control the formula. They don't control, you mentioned the NDAs. They can't talk to manufacturers, so they can't go to Novo or to Lilly and say, let's put together a GLP-1 wellness program. All these different things that just are common sense. It's not happening. And so, the good news is when I walk into these companies that self-insured and talk to the CEO or CFO, I'm not asking them to do something that's not in their best interest or not in the best interest of the lives they cover. I'm saying, we can save you money and you can improve the wellness of your employees and their families. Where's the downside?Eric Topol (04:40):Oh, yeah. Yeah. And the reason they can't see the claims is because of the privacy issues?Mark Cuban (04:46):No, no. That's just a business decision in the contract that the PBMs have made. You can go and ask. I mean, you have every right to your own claims. You don't need to have it personally identified. You want to find out how many people have GLP-1s or what are the trends, or God forbid there's another Purdue Pharma thing going on, and someone prescribing lots of opioids. You want to be able to see those things, but they won't do it. And that's only on the sponsor side. It's almost as bad if not worse on the manufacturer side.Eric Topol (05:20):Oh, yeah. Well, some of the work of PBMs that you've been talking about were well chronicled in the New York Times, a couple of major articles by Reed Abelson and Rebecca Robbins: The Opaque Industry Secretly Inflating Prices for Prescription Drugs and The Powerful Companies Driving Local Drugstores Out of Business. We'll link those because I think some people are not aware of all the things that are going on in the background.Mark Cuban (05:39):You see in their study and what they reported on the big PBMs, it's crazy the way it works. And literally if there was transparency, like Cost Plus offers, the cost of medications across the country could come down 20%, 30% or more.Cost Plus DrugsEric Topol (05:55):Oh, I mean, it is amazing, really. And now let's get into Cost Plus. I know that a radiologist, Alex Oshmyansky contacted you with a cold email a little over three years ago, and you formed Cost Plus Drugs on the basis of that, right?Mark Cuban (06:12):Yep, that's exactly what happened.Eric Topol (06:15):I give you credit for responding to cold emails and coming up with a brilliant idea with this and getting behind it and putting your name behind it. And what you've done, so you started out with something like 110 generics and now you're up well over 1,200 or 2,500 or something like that?Mark Cuban (06:30):And adding brands. And so, started with 111. Now we're around 2,500 and trying to grow it every single day. And not only that, just to give people an overview. When you go to www.costplusdrugs.com and you put in the name of your medication, let's just say it's tadalafil, and if it comes up. In this case, it will. It'll show you our actual cost, and then we just mark it up 15%. It's the same markup for everybody, and if you want it, we'll have a pharmacist check it. And so, that's a $5 fee. And then if you want ship to mail order, it's $5 for shipping. And if you want to use our pharmacy network, then we can connect you there and you can just pick it up at a local pharmacy.Eric Topol (07:10):Yeah, no, it's transparency. We don't have a lot of that in healthcare in America, right?Mark Cuban (07:15):No. And literally, Eric, the smartest thing that we did, and we didn't expect this, it's always the law of unintended consequences. The smartest thing we did was publish our entire price list because that allowed any company, any sponsor, CMS, researchers to compare our prices to what others were already paying. And we've seen studies come out saying, for this X number of urology drugs, CMS would save $3.6 billion a year. For this number of heart drugs at this amount per year, for chemotherapy drugs or MS drugs this amount. And so, it's really brought attention to the fact that for what PBMs call specialty drugs, whether there's nothing special about them, we can save people a lot of money.Eric Topol (08:01):It's phenomenal. As a cardiologist, I looked up a couple of the drugs that I'm most frequently prescribed, just like Rosuvastatin what went down from $134 to $5.67 cents or Valsartan it went down from $69 to $7.40 cents. But of course, there's some that are much more dramatic, like as you mentioned, whether it's drugs for multiple sclerosis, the prostate cancer. I mean, some of these are just thousands and thousands of dollars per month that are saved, brought down to levels that you wouldn't think would even be conceivable. And this has been zero marketing, right?Mark Cuban (08:42):Yeah, none. It's all been word of mouth and my big mouth, of course. Going out there and doing interviews like this and going to major media, but it's amazing. We get emails and letters and people coming up to us almost single day saying, you saved my grandma's life. You saved my life. We weren't going to be able to afford our imatinib or our MS medication. And it went from being quoted $2,000 a month to $33 a month. It's just insane things like that that are still happening.Eric Topol (09:11):Well, this is certainly one of the biggest shakeups to occur in US healthcare in years. And what you've done in three years is just extraordinary. This healthcare in this country is with its over 4 trillion, pushing $5 trillion a year of expenditure.[New CMS report this week pegs the number at $4.867 trillion for 2023]Mark Cuban (09:30):It's interesting. I think it's really fixable. This has been the easiest industry to the disrupt I've ever been involved in. And it's not even close because all it took was transparency and not jacking up margins to market. We choose to use a fixed margin markup. Some choose to price to market, the Martin Shkreli approach, if you will. And just by being transparent, we've had an impact. And the other side of it is, it's the same concept on the healthcare side. Transparency helps, but to go a little field of pharmacy if you want. The insane part, and this applies to care and pharmacy, whatever plan we have, whether it's for health or whether it's for pharmaceuticals, there's typically a deductible, typically a copay, and typically a co-insurance.Insurance CompaniesMark Cuban (10:20):The crazy part of all that is that people taking the default risk, the credit risk are the providers. It's you, it's the hospital, it's the clinics that you work for. Which makes no sense whatsoever that the decisions that you or I make for our personal insurance or for the companies we run, or if we work for the government, what we do with Medicare or Medicare Advantage, the decisions we all make impacts the viability of providers starting with the biggest hospital systems. And so, as a result, they become subprime lenders without a car or a house to go after if they can't collect. And so, now you see a bunch of people, particularly those under the ACA with the $9,000, the bronze plans or $18,000 out-of-pocket limits go into debt, significant medical debt. And it's unfortunate. We look at the people who are facing these problems and think, well, it must be the insurance companies.Mark Cuban (11:23):It's actually not even the insurance companies. It's the overall design of the system. But underneath that, it's still whoever picks the insurance companies and sets plans that allow those deductibles, that's the core of the problem. And until we get to a system where the providers aren't responsible for the credit for defaults and dealing with all that credit risk, it's almost going to be impossible to change. Because when you see stories like we've all seen in news of a big healthcare, a BUCA healthcare (Blue Cross Blue Shield (BCBS), UnitedHealth, Cigna, and Aetna/CVS) plan with all the pre-authorizations and denials, typically they're not even taking the insurance risk. They're acting as the TPA (third party administrator) as the claims processor effectively for whoever hired them. And it goes back again, just like I talked about before. And as long as CMS hires or allows or accepts these BUCAs with these plans for Medicare for the ACA (Affordable care Act), whatever it may be, it's not going to work. As long as self-insured employers and the 50 million lives they cover hire these BUCAs to act as the TPAs, not as insurance companies and give them leeway on what to approve and what to authorize and what not to authorize. The system's going to be a mess, and that's where we are today.Academic Health System PartnershipsEric Topol (12:41):Yeah. Well, you've been talking of course to employers and enlightening them, and you're also enlightening the public, of course. That's why you have millions of people that are saving their cost of medications, but recently you struck a partnership with Penn Medicine. That's amazing. So is that your first academic health system that you approached?Cost Plus MarketplaceMark Cuban (13:00):I don't know if it was the first we approached, but it was certainly one of the biggest that we signed. We've got Cost Plus Marketplace (CPM) where we make everything from injectables to you name it, anything a hospital might buy. But again, at a finite markup, we make eight and a half percent I think when it's all said and done. And that saves hospital systems millions of dollars a year.Eric Topol (13:24):Yeah. So that's a big change in the way you're proceeding because what it was just pills that you were buying from the pharma companies, now you're actually going to make injectables and you're going to have a manufacturing capability. Is that already up and going?Mark Cuban (13:39):That's all up and going as of March. We're taking sterile injectables that are on the shortage list, generic and manufacturing them in Dallas using a whole robotics manufacturing plant that really Alex created. He's the rocket scientist behind it. And we're limited in capacity now, we're limited about 2 million vials, but we'll sell those to Cost Plus Marketplace, and we'll also sell those direct. So Cost Plus Marketplace isn't just the things we manufacture. It's a wide variety of products that hospitals buy that we then have a minimal markup, and then for the stuff we manufacture, we'll sell those to direct to like CHS was our first customer.Eric Topol (14:20):Yeah, that's a big expansion from going from the pills to this. Wow.Mark Cuban (14:24):It's a big, big expansion, but it goes to the heart of being transparent and not being greedy, selling on a markup. And ourselves as a company, being able to remain lean and mean. The only way we can sell at such a low markup. We have 20 employees on the Cost Plus side and 40 employees involved with the factories, and that's it.Eric Topol (14:46):Wow. So with respect to, you had this phenomenal article and interview with WIRED Magazine just this past week. I know Lauren Goode interviewed you, and she said, Mark, is this really altruistic and I love your response. You said, “how much f*****g money do I need? I'm not trying to land on Mars.” And then you said, “at this point in my life, it's just like more money, or f**k up the healthcare industry.” This was the greatest, Mark. I mean, I got to tell you, it was really something.Mark Cuban (15:18):Yeah.Eric Topol (15:19):Well, in speaking of that, of course, the allusion to a person we know well, Elon. He posted on X/Twitter in recent days , I think just three or four days ago, shouldn't the American people be getting their money's worth? About this high healthcare administration costs where the US is completely away from any other OECD country. And as you and I know, we have the worst outcomes and the most costs of all the rich countries in the world. There's just nothing new here. Maybe it's new to him, but you had a fabulous response on both X and Bluesky where you went over all these things point by point. And of course, the whole efforts that you've been working on now for three years. You also mentioned something that was really interesting that I didn't know about were these ERISA lawsuits[Employee Retirement Income Security Act (ERISA) of 1974.] Can you tell us about that?ERISA LawsuitsMark Cuban (16:13):Yeah, that's a great question, Eric. So for self-insured companies in particular, we have a fiduciary responsibility on a wellness and on a financial basis to offer the members, your employees and their families the best outcomes at the best price. Now, you can't guarantee best outcomes, but you have to be able to explain the choices you made. You don't have to pick the cheapest, but again, you have to be able to explain why you made the choices that you did. And because a lot of companies have been doing, just like we discussed earlier, doing deals on the pharmacy side with just these big PBMs, without accounting for best practices, best price, best outcomes, a couple companies got sued. Johnson and Johnson and Wells Fargo were the first to get sued. And I think that's just the beginning. That's just the writing on the wall. I think they'll lose because they just dealt with the big pharmacy PBMs. And I think that's one of the reasons why we're so busy at Cost Plus and why I'm so busy because we're having conversation after conversation with companies and plenty of enough lawyers for that matter who want to see a price list and be able to compare what they're paying to what we sell for to see if they're truly living up to that responsibility.Eric Topol (17:28):Yeah, no, that's a really important thing that's going on right now that I think a lot of people don't know about. Now, the government of the US think because it's the only government of any rich country in the world, if not any country that doesn't negotiate prices, i.e., CMS or whatever. And only with the recent work of insulin, which is a single one drug, was there reduction of price. And of course, it's years before we'll see other drugs. How could this country not negotiate drugs all these years where every other place in the world they do negotiate with pharma?Mark Cuban (18:05):Because as we alluded to earlier, the first line in every single pharmaceutical and healthcare contract says, you can't talk about this contract. It's like fight club. The number one rule of fight club is you can't talk about fight club, and it's really difficult to negotiate prices when it's opaque and everything's obfuscated where you can't really get into the details. So it's not that we're not capable of it, but it's just when there's no data there, it's really difficult because look, up until we started publishing our prices, how would anybody know?Mark Cuban (18:39):I mean, how was anybody going to compare numbers? And so, when the government or whoever started to negotiate, they tried to protect themselves and they tried to get data, but those big PBMs certainly have not been forthcoming. We've come along and publish our price list and all that starts to change. Now in terms of the bigger picture, there is a solution there, as I said earlier, but it really comes down to talking to the people who make the decisions to hire the big insurance companies and the big PBMs and telling them, no, you're not acting in your own best interest. Here's anybody watching out there. Ask your PBM if they can audit. If you can audit rather your PBM contract. What they'll tell you is, yeah, you can, but you have to use our people. It's insane. And that's from top to bottom. And so, I'm a big believer that if we can get starting with self-insured employers to act in their own best interest, and instead of working with a big PBM work with a pass-through PBM. A pass-through PBM will allow you to keep your own claims, own all your own data, allow you to control your own formulary.Mark Cuban (19:54):You make changes where necessary, no NDA, so you can't talk to manufacturers. All these different abilities that just seem to make perfect sense are available to all self-insured employers. And if the government, same thing. If the government requires pass-through PBMs, the price of medications will drop like a rock.Eric Topol (20:16):Is that possible? You think that could happen?Mark Cuban (20:19):Yes. Somebody's got to understand it and do it. I'm out there screaming, but we will see what happens with the new administration. There's nothing hard about it. And it's the same thing with Medicare and Medicare Advantage healthcare plans. There's nothing that says you have to use the biggest companies. Now, the insurance companies have to apply and get approved, but again, there's a path there to work with companies that can reduce costs and improve outcomes. The biggest challenge in my mind, and I'm still trying to work through this to fully understand it. I think where we really get turned upside down as a country is we try to avoid fraud from the provider perspective and the patient perspective. We're terrified that patients are going to use too much healthcare, and like everybody's got Munchausen disease.Mark Cuban (21:11):And we're terrified that the providers are going to charge too much or turn into Purdue Pharma and over-prescribe or one of these surgery mills that just is having somebody get surgery just so they can make money. So in an effort to avoid those things, we ask the insurance companies and the PBMs to do pre-authorizations, and that's the catch 22. How do we find a better way to deal with fraud at the patient and provider level? Because once we can do that, and maybe it's AI, maybe it's accepting fraud, maybe it's imposing criminal penalties if somebody does those things. But once we can overcome that, then it becomes very transactional. Because the reality is most insurance companies aren't insurance companies. 50 million lives are covered by self-insured employers that use the BUCAs, the big insurance companies, but not as insurance companies.Eric Topol (22:07):Yeah, I was going to ask you about that because if you look at these three big PBMs that control about 80% of the market, not the pass-throughs that you just mentioned, but the big ones, they each are owned by an insurance company. And so, when the employer says, okay, we're going to cover your healthcare stuff here, we're going to cover your prescriptions there.Mark Cuban (22:28):Yeah, it's all vertically integrated.Mark Cuban (22:36):And it gets even worse than that, Eric. So they also own specialty pharmacies, “specialty pharmacies” that will require you to buy from. And as I alluded to earlier, a lot of these medications like Imatinib, they'll list as being a specialty medication, but it's a pill. There's nothing special about it, but it allows them to charge a premium. And that's a big part of how the PBMs make a lot of their money, the GPO stuff we talked about, but also forcing an employer to go through the specialty mail order company that charges an arm and the leg.Impact on Hospitals and ProceduresEric Topol (23:09):Yeah. Well, and the point you made about transparency, we've seen this of course across US healthcare. So for example, as you know, if you were to look at what does it cost to have an operation like let's say a knee replacement at various hospitals, you can find that it could range fivefold. Of course, you actually get the cost, and it could be the hospital cost, and then there's the professional cost. And the same thing occurs for if you're having a scan, if you're having an MRI here or there. So these are also this lack of transparency and it's hard to get to the numbers, of course. There seems to be so many other parallels to the PBM story. Would you go to these other areas you think in the future?Mark Cuban (23:53):Yeah, we're doing it now. I'm doing it. So we have this thing called project dog food, and what it is, it's for my companies and what we've done is say, look, let's understand how the money works in healthcare.Mark Cuban (24:05):And when you think about it, when you go to get that knee done, what happens? Well, they go to your insurance company to get a pre-authorization. Your doctor says you need a knee replacement. I got both my hips replaced. Let's use that. Doctor says, Mark, you need your hips replaced. Great, right? Let's set up an appointment. Well, first the insurance company has to authorize it, okay, they do or they don't, but the doctor eats their time up trying to deal with the pre-authorization. And if it's denied, the doctor's time is eaten up and an assistance's time is eaten up. Some other administrator's time is eaten up, the employer's time is eaten up. So that's one significant cost. And then from there, there's a deductible. Now I can afford my deductible, but if there is an individual getting that hip replacement who can't afford the deductible, now all of a sudden you're still going to be required to do that hip replacement, most likely.Mark Cuban (25:00):Because in most of these contracts that self-insured employers sign, Medicare Advantage has, Medicare has, it says that between the insurance company and the provider, in this case, the hospital, you have to do the operation even if the deductibles not paid. So now the point of all this is you have the hospital in this case potentially accumulating who knows how much bad debt. And it's not just the lost amount of millions and millions and billions across the entire healthcare spectrum that's there. It's all the incremental administrative costs. The lawyers, the benefits for those people, the real estate, the desk, the office space, all that stuff adds up to $10 billion plus just because the hospitals take on that credit default risk. But wait, there's more. So now the surgery happens, you send the bill to the insurance company. The insurance company says, well, we're not going to pay you. Well, we have a contract. This is what it says, hip replacement's $34,000. Well, we don't care first, we're going to wait. So we get the time value of money, and then we're going to short pay you.Mark Cuban (26:11):So the hospital gets short paid. So what do they have to do? They have to sue them or send letters or whatever it is to try to get their money. When we talk to the big hospital systems, they say that's 2%. That's 2% of their revenue. So you have all these associated credit loss dollars, you've got the 2% of, in a lot of cases, billions and billions of dollars. And so, when you add all those things up, what happens? Well, what happens is because the providers are losing all that money and having to spend all those incremental dollars for the administration of all that, they have to jack up prices.Eric Topol (26:51):Yeah. Right.Mark Cuban (26:53):So what we have done, we've said, look for my companies, we're going to pay you cash. We're going to pay you cash day one. When Mark gets that hip replacement, that checks in the bank before the operation starts, if that's the way you want it. Great, they're not going to have pre-authorizations. We're going to trust you until you give us a reason not to trust you. We're not short paying, obviously, because we're paying cash right there then.Mark Cuban (27:19):But in a response for all that, because we're cutting out all those ancillary costs and credit risk, I want Medicare pricing. Now the initial response is, well, Medicare prices, that's awful. We can't do it. Well, when you really think about the cost and operating costs of a hospital, it's not the doctors, it's not the facilities, it's all the administration that cost all the money. It's all the credit risks that cost all the money. And so, if you remove that credit risk and all the administration, all those people, all that real estate, all those benefits and overhead associated with them, now all of a sudden selling at a Medicare price for that hip replacement is really profitable.Eric Topol (28:03):Now, is that a new entity Cost Plus healthcare?Mark Cuban (28:07):Well, it's called Cost Plus Wellness. It's not an entity. What we're going to do, so the part I didn't mention is all the direct contracts that we do that have all these pieces, as part of them that I just mentioned, we're going to publish them.Eric Topol (28:22):Ah, okay.Mark Cuban (28:23):And you can see exactly what we've done. And if you think about the real role of the big insurances companies for hospitals, it's a sales funnel.Getting Rid of Insurance CompaniesEric Topol (28:33):Yeah, yeah. Well, in fact, I really was intrigued because you did a podcast interview with Andrew Beam and the New England Journal of Medicine AI, and in that they talked about getting rid of the insurers, the insurance industry, just getting rid of it and just make it a means test for people. So it's not universal healthcare, it's a different model that you described. Can you go over that? I thought it was fantastic.Mark Cuban (29:00):Two pieces there. Let's talk about universal healthcare first. So for my companies, for our project dog food for the Mark Cuban companies, if for any employee or any of the lives we cover, if they work within network, anybody we have the direct contract with its single-payer. They pay their premiums, but they pay nothing else out of pocket. That's the definition of single-payer.Eric Topol (29:24):Yeah.Mark Cuban (29:25):So if we can get all this done, then the initial single-payers will be self-insured employers because it'll be more cost effective to them to do this approach. We hope, we still have to play it all through. So that's part one. In terms of everybody else, then you can say, why do we need insurance companies if they're not even truly acting as insurance companies? You're not taking full risk because even if it's Medicare Advantage, they're getting a capitated amount per month. And then that's getting risk adjusted because of the population you have, and then there's also an index depending on the location, so there's more or less money that occurs then. So let's just do what we need to do in this particular case, because the government is effectively eliminating the risk for the insurance company for the most part. And if you look at the margins for Medicare Advantage, I was just reading yesterday, it's like $1,700 a year for the average Medicare Advantage plan. So it's not like they're taking a lot of risk. All they're doing is trying to deny as many claims as they can.Eric Topol (30:35):Deny, Deny. Yeah.Mark Cuban (30:37):So instead, let's just get somebody who's a TPA, somebody who does the transaction, the claims processing, and whoever's in charge. It could be CMS, can set the terms for what's accepted and what's denied, and you can have a procedure for people that get denied that want to challenge it. And that's great, there's one in place now, but you make it a little simpler. But you take out the economics for the insurance company to just deny, deny, deny. There's no capitation. There's no nothing.Mark Cuban (31:10):The government just says, okay, we're hiring this TPA to handle the claims processing. It is your job. We're paying you per transaction.Mark Cuban (31:18):You don't get paid more if you deny. You don't get paid less if you deny. There's no bonuses if you keep it under a certain amount, there's no penalties If you go above a certain amount. We want you just to make sure that the patient involved is getting the best care, end of story. And if there's fraud involved as the government, because we have access to all that claims data, we're going to introduce AI that reviews that continuously.Mark Cuban (31:44):So that we can see things that are outliers or things that we question, and there's going to mean mistakes, but the bet was, if you will, where we save more and get better outcomes that way versus the current system and I think we will. Now, what ends up happening on top of that, once you have all that claims data and all that information and everybody's interest is aligned, best care at the best price, no denials unless it's necessary, reduce and eliminate fraud. Once everybody's in alignment, then as long as that's transparent. If the city of Dallas decides for all the lives they cover the 300,000 lives they cover between pharmacy and healthcare, we can usually in actuarial tables and some statistical analysis, we can say, you know what, even with a 15% tolerance, it's cheaper for us just to pay upfront and do this single-pay program, all our employees in the lives we cover, because we know what it's going to take.Mark Cuban (32:45):If the government decides, well, instead of Medicare Advantage the way it was, we know all the costs. Now we can say for all Medicare patients, we'll do Medicare for all, simply because we have definitive and deterministic pricing. Great. Now, there's still going to be outlier issues like all the therapies that cost a million dollars or whatever. But my attitude there is if CMS goes to Lilly, Novo, whoever for their cure for blindness that's $3.4 million. Well, that's great, but what we'll say is, okay, give us access to your books. We want to know what your breakeven point is. What is that breakeven point annually? We'll write you a check for that.Eric Topol (33:26):Yeah.Mark Cuban (33:27):If we have fewer patients than need that, okay, you win. If we have more patients than need that, it's like a Netflix subscription with unlimited subscribers, then we will have whatever it is, because then the manufacturer doesn't lose money, so they can't complain about R&D and not being able to make money. And that's for the CMS covered population. You can do a Netflix type subscription for self-insured employers. Hey, it's 25 cents per month per employee or per life covered for the life of the patent, and we'll commit to that. And so, now all of a sudden you get to a point where healthcare starts becoming not only transparent but deterministic.Eric Topol (34:08):Yeah. What you outline here in these themes are extraordinary. And one of the other issues that you are really advocating is patient empowerment, but one of the problems we have in the US is that people don't own their data. They don't even have all their data. I expect you'd be a champion of that as well.Mark Cuban (34:27):Well, of course. Yeah. I mean, look, I've got into arguments with doctors and public health officials about things like getting your own blood tested. I've been an advocate of getting my own blood tested for 15 years, and it helped me find out that I needed thyroid medication and all of these things. So I'm a big advocate. There's some people that think that too much data gives you a lot of false positives, and people get excited in this day and age to get more care when it should only be done if there are symptoms. I'm not a believer in that at all. I think now, particularly as AI becomes more applicable and available, you'll be able to be smarter about the data you capture. And that was always my final argument. Either you trust doctors, or you don't. Because even if there's an aberrational TSH reading and minus 4.4 and it's a little bit high, well the doctor's going to say, well, let's do another blood test in a month or two. The doctor is still the one that has to write the prescription. There's no downside to trusting your doctor in my mind.Eric Topol (35:32):And what you're bringing up is that we're already seeing how AI can pick up things even in the normal range, the trends long before a clinician physician would pick it up. Now, last thing I want to say is you are re-imagining healthcare like no one. I mean, there's what you're doing here. It started with some pills and it's going in a lot of different directions. You are rocking it here. I didn't even know some of the latest things that you're up to. This seems to be the biggest thing you've ever done.Mark Cuban (36:00):I hope so.Mark Cuban (36:01):I mean, like we said earlier, what could be better than people saying our healthcare system is good. What changed? That Cuban guy.Eric Topol (36:10):Well, did you give up Shark Tank so you could put more energy into this?Mark Cuban (36:16):Not really. It was more for my kids.Eric Topol (36:19):Okay, okay.Mark Cuban (36:20):They go hand in hand, obviously. I can do this stuff at home as opposed to sitting on a set wondering if I should invest in Dude Wipes again.Eric Topol (36:28):Well, look, we're cheering for you. This is, I've not seen a shakeup in my life in American healthcare like this. You are just rocking. It's fantastic.Mark Cuban (36:37):Everybody out there that's watching, check out www.costplusdrugs.com, check out Cost Plus Marketplace, which is business.costplusdrugs.com and just audit everything. What I'm trying to do is say, okay, if it's 1955 and we're starting healthcare all over again, how would we do it? And really just keep it simple. Look to where the risk is and remove the risk where possible. And then it comes down to who do you trust and make sure you trust but verify. Making sure there aren't doctors or systems that are outliers and making sure that there aren't companies that are outliers or patients rather that are outliers. And so, I think there's a path there. It's not nearly as difficult, it's just starting them with corporations, getting those CEOs to get educated and act in their own best interest.Eric Topol (37:32):Well, you're showing us the way. No question. So thanks so much for joining, and we'll be following this with really deep interest because you're moving at high velocity, and thank you.**************************************************Thank you for reading, listening and subscribing to Ground Truths.If you found this fun and informative please share it!All content on Ground Truths—its newsletters, analyses, and podcasts, are free, open-access.Paid subscriptions are voluntary. All proceeds from them go to support Scripps Research. Many thanks to those who have contributed—they have greatly helped fund our summer internship programs for the past two years. I welcome all comments from paid subscribers and will do my best to respond to each of them and any questions.Thanks to my producer Jessica Nguyen and to Sinjun Balabanoff for audio and video support at Scripps Research.FootnoteThe PBMS (finally) are under fire—2 articles from the past week Get full access to Ground Truths at erictopol.substack.com/subscribe

Mastering the mind, living astrology, getting curious and understanding our inner workings with Emma Mikalina  Lauren Grace is joined by Emma Mikalina for a thought-provoking discussion on mastering the mind and living astrology. Together, they explore: ✨ Getting curious about your thoughts and detaching from them ✨ Understanding your inner workings and peeling back the layers of the mind ✨ Growing through emotions and choosing to move beyond grief ✨ Searching for deeper truth and meaning This episode is your guide to self-discovery and aligning with the universe. Listen now. ----more---- Welcome to The Afterlight Podcast with Lauren Grace, a spiritual podcast full of stories and conversations that prove we're never alone. Lauren Grace, host of The Afterlight Podcast, is a high-impact coach and medium dedicated to helping professionals deepen their connection to their soul so they can experience more freedom, fulfillment, and purpose.   Connect with Lauren Grace, Lauren Grace Inspirations: Lauren on Social @LaurenGraceInspirations Website: https://laurengraceinspirations.com Want to work with Lauren? Book a Free Discovery Call with Lauren: https://laurengraceinspirations.com Free Offers: https://laurengraceinspirations.com/freeoffers   The Afterlight Podcast:  The Afterlight Podcast on Social @theafterlightpodcast To be a guest, apply here: www.theafterlightpodcast.com Sign up for our newsletter: https://laurengraceinspirations.com/contact   Connect with Emma here Emma Mikalina  is a spiritual mentor and educator of astrology, esotericism, living wisdom and soul science. Connect here: https://emmamikalina.com/      

November 22nd, 2024

Running the world's busiest airport isn't for the faint-hearted. It demands bold vision, relentless strategy, and the grit to tackle high-stakes challenges day in, day out. Dubai Airports CEO Paul Griffiths knows this better than anyone. In this episode of Unscripted with Spencer Lodge, Paul gives us a front-row seat to the realities of leading in the aviation industry, sharing the strategies that keep Dubai Airports ahead of the curve and his ambitious vision for the future of air travel. We dive into his approach to enhancing the passenger experience, Dubai Airports' focus on innovation, and how he's tackling the critical balance between convenience and sustainability.  This episode is packed with hard-hitting insights on leadership, growth, and the drive required to run a world-class airport. Don't miss it! 02:47 – Paul's journey to aviation 13:11 – The influence of religion on Paul's life and career 24:15 – The Hawker Siddeley Harrier Jump Jet 29:39 – Paul's experience with major players like Virgin and Gatwick Airport 30:05 – Leadership insights 45:53 – Paul's approach to improving the airport experience 55:02  – Details about Dubai Airport's facilities and innovations 59:21 – Environmental challenges in the aviation industry Show Sponsors: Allsopp & Allsopp: Redefining real estate, through cutting-edge technology and setting new standards for seamless, elevated customer experience. Keep moving with Allsopp & Allsopp.https://bit.ly/Allsopp-and-Allsopp Socials: Spencer Lodgehttps://www.instagram.com/spencer.lodge/?hl=en https://www.tiktok.com/@spencer.lodge https://www.linkedin.com/in/spencerlodge/ https://www.youtube.com/c/SpencerLodgeTV https://www.facebook.com/spencerlodgeofficial/  Paul Griffithshttps://www.linkedin.com/in/paul-griffiths-aaa87b2/

Please join us, as Pastor Britt continues our series on holiness. We're so thankful you are here with us.

Australia's intelligence head says none of the nine terror attacks, disruptions, or incidents this year have been directly inspired by the conflict in the Middle East. After raising Australia's terror threat level earlier this year over concerns of a destabilising security environment, the Australian Security Intelligence Organisation says those concerns have now been proven correct.

November 6th, 2024

Australia's intelligence head says none of the nine terror attacks, disruptions, or incidents this year have been directly inspired by the conflict in the Middle East. After raising Australia's terror threat level earlier this year over concerns of a destablising security environment, the Australian Security Intelligence Organisation says those concerns have now been proven correct.

October 30th, 2024

Wednesday October, 16 2024

Harper Carroll is an AI and Machine Learning software engineer and educator known for making complex AI concepts accessible to a wide audience. She has multiple degrees from Stanford University in Computer Science specializing in AI, and industry experience at Meta, working on augmented reality and civic integrity projects. Her online educational content has gained her a following of over 300,000 subscribers on Instagram and YouTube.Harper's 10 Days of AI BasicsAI Avatar Demonstration10 Days of AI x Nuclear: AI's Energy NeedsGround News gathers news coverage from around the world, empowers free thinking, and makes media bias explicit. Subscribe through my link at https://check.ground.news/Next for 15% off your subscription.If You Liked This Conversation, You'll Probably Like These Episodes of Where We Go Next:115: Spaceships, Silicon Valley, and Psilocybin, with Ashlee Vance111: The Hidden Forces Driving Our Online Behavior, with Steve Rathje104: The War for Critical Minerals and Our Electrified Future, with Ernest Scheyder92: Bayesian Thinking and the Future of Artificial Intelligence, with Max Sklar89: Harnessing the Revolutionary Power of Nuclear Energy, with Nick Touran52: The Amazing and Optimistic Future of Augmented Reality, with David Rose47: A New Philosophy of Progress and Why We Don't Have Flying Cars, with Jason Crawford27: How to Make the Internet Accessible for Everyone, with Jennison Asuncionharpercaroll.aiFollow Harper on Instagram: @harpercarrollaiFollow Harper on YouTube: @harpercarrollaiFollow Harper on TikTok: @harpercarrollaiFollow Harper on X: @harpercarrollFollow Harper on Patreon: @harpercarrollai----------If you liked this episode, consider sharing it with someone you think might like it too.Email: michael@wherewegonext.comInstagram: @wwgnpodcast

Gartner's unique culture is one of our greatest strengths. But how do we cultivate that culture in a hybrid and global work environment? And why are team connections so important?  In this episode of Inner Workings, six leaders from across the business share how they keep their teams connected – and some of their favorite memories with their teams. 

October 9th 2024

James Hergott talks about " All That I Need" his true movie where a group of people starts a money pyramid scheme. As they start to make major money, jealousy and greed enter the picture. Their friendships are tested when they start to turn on each other. James Website https://jameshergott.com Movie Trailer. https://www.youtube.com/watch?v=JVLR08Zpxho Follow me on all socials! Twitter: http://www.twitter.com/matthewcoxitc Instagram: https://www.instagram.com/insidetruecrime/ TikTok: https://www.tiktok.com/@matthewcoxcrime Follow my 2nd channel - Inside The Darkness! https://www.youtube.com/c/InsidetheDarknessAutobiographies Want to be a guest? Send me an email here! insidetruecrime@gmail.com Want a custom Con man painting shown up at your doorstep every month? Subscribe to Patreon! https://www.patreon.com/insidetruecrime Get a custom painting done by me! Check out my link! https://www.etsy.com/shop/coxpopart Listen to True Crime Podcasts anywhere! https://anchor.fm/mattcox Check out my prison story books here! https://www.amazon.com/Matthew-Cox/e/B08372LKZG Support me here! Paypal: https://www.paypal.me/MattCox69 Cashapp: $coxcon69 --- Support this podcast: https://podcasters.spotify.com/pod/show/mattcox/support

Dan is joined by Andrea Gallo, Vice President of Technology at RISC-V International. Andrea heads up the Technical Activities in collaboration with RISC-V members across workgroups and committees in growing the adoption of the RISC-V Instruction Set Architecture. Prior to RISC-V International, Andrea held multiple roles… Read More

Geoffrey Shugen Arnold, Roshi - ZMM - 9/27/24 - What we need to understand about karma is basically that the web of causation is vast and far beyond our conscious comprehension. By taking responsibility for our thoughts, words and actions, we are setting the course for wholesome actions. This is the heart of moral and ethical teachings, and the nature of the enlightened mind itself.

Unlock the secrets to manifestation mastery by avoiding common pitfalls in this eye-opening episode!

In this episode of After Earnings, Katie talks with Mike Walrath, CEO of Yext, about digital presence management. Mike explains how Yext helps companies keep their online info accurate, which is key for revenue and customer satisfaction. They discuss challenges from AI and the need for reliable data, plus Yext's recent acquisition of Hearsay and AI's growing role in business. 00:00 START  01:28 The Importance of Accurate Digital Data 03:30 AI's Impact on Search and Data Accuracy 06:56 Klarna's Bold Move and SaaS Industry Insights 09:05 Balancing Innovation and Customer Needs 11:01 Yext's Recent Earnings and Future Focus 17:30 The Evolution of Digital Advertising 21:34 Reflections on Education and Career Paths $YEXT After Earnings is brought to you by Stakeholder Labs and Morning Brew. For more go to https://www.afterearnings.com Follow Us X: https://twitter.com/AfterEarnings   TikTok: https://www.tiktok.com/@AfterEarnings   Instagram: https://www.instagram.com/afterearnings_ /  Reach Out Email: afterearnings@morningbrew.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Welsh duo The Bug Club combine high-energy, melodic garage rock with absurd, witty lyrics on their Sub Pop debut, "On the Intricate Inner Workings of the System." We discuss it in-depth in episode #218 of “For the Record.”

A new film provides a behind-the-scenes look at the lives of New York City psychics. Director Lana Wilson joins us to discuss her documentary, "Look Into My Eyes" which releases in theaters Friday, September 6. 

Drug cartels employ a complex and sophisticated logistical network to move drugs across international borders. This network includes several key components:1. Production and PackagingCocaine: Produced in the Andean region (Colombia, Peru, Bolivia) from coca plants, refined into cocaine hydrochloride, and packaged in innovative ways to avoid detection.Heroin: Derived from opium poppies in Mexico and Afghanistan, processed into heroin, and often hidden in compressed bricks or disguised in other substances.Methamphetamine: Manufactured in large-scale "super labs" in Mexico, using precursor chemicals smuggled from countries like China and India.Synthetic Drugs: Includes fentanyl and ecstasy, produced in clandestine labs using chemicals from China, often disguised as prescription drugs or other products.2. Transportation NetworksLand Routes: Drugs are moved through Central America and Mexico using convoys, hidden compartments in vehicles, and bribed officials. Cartels often use legitimate businesses as fronts for smuggling operations.Maritime Routes: Cartels utilize narco-submarines, cargo ships, fishing vessels, and go-fast boats to transport drugs across oceans, often transferring them at sea to avoid detection.Air Routes: Private jets, light aircraft, and commercial airlines are used, with drugs hidden in luggage, body cavities, or the aircraft structure. Airdrops in remote areas are also common.Tunnels: Sophisticated cross-border tunnels equipped with lighting and ventilation are dug under the U.S.-Mexico border, allowing drugs to bypass checkpoints.3. Corruption and BriberyLaw Enforcement: Cartels bribe police, customs officials, and military personnel to ignore or facilitate drug shipments. Corruption extends to turning law enforcement officers into cartel operatives.Political Corruption: High-level bribery of politicians ensures protection from prosecution and favorable policy decisions.Corporate Corruption: Legitimate businesses are infiltrated or co-opted to facilitate smuggling and money laundering.4. Distribution and Money LaunderingDistribution Networks: Drugs are stored in safe houses and distributed through local gangs or independent distribution cells in major cities.Money Laundering: Cartels use shell companies, trade-based money laundering, real estate investments, and cryptocurrencies to clean illicit profits and reintegrate them into the legal economy.5. Technology and InnovationDrones: Used for surveillance and transporting small drug shipments across borders.Cryptocurrency: Facilitates anonymous transactions and money laundering.Encrypted Communication: Custom encryption tools and devices protect cartel communications from law enforcement.Counter-Surveillance: Use of lookouts, advanced technology, and signal jamming to evade or disrupt law enforcement operations.In this episode, we take a look behind the curtain at the logistics behind transnational criminal groups.(commercial at 10:26)to contact me:bobbycapucci@protonmail.com

Joe Moore, a former Army sniper turned FBI informant, shares how he infiltrated the KKK and helped foil a plot to assassinate then Sen. Barack Obama. Moore explains how hate groups are growing. His new book is 'White Robes and Broken Badges.'Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

At Gartner, we believe that nurturing new talent is critical to building a strong and innovative future. But how do leaders actually support entry-level employees in practice? And what steps can they take to ensure these new professionals thrive? In this episode of Inner Workings, seven leaders from across the business share their approaches to fostering the growth and success of entry-level talent. 

Special guests Mike Liddell (IG mr_liddell) and Erik Griggs aka Blu2th (IG blu2th) joined the Writers Refuge to freestyle a tight story about the "background" inner workings of the Super Bowl. MooreSubstance@gmail.com Potluck preorder book Barry Tyson preorder book

Chapter 1:Summary of Gut"Gut" by Giulia Enders is a comprehensive and accessible exploration of the human digestive system. Enders, a microbiologist, provides detailed explanations of how the gut works, from how food is processed to the role of gut bacteria in digestion and overall health. She also covers common digestive issues such as constipation, bloating, and food intolerances, offering practical tips for maintaining gut health. Overall, "Gut" is a fascinating and informative read that sheds light on the importance of gut health in maintaining overall well-being.Chapter 2:The Theme of GutKey plot points in "Gut" by Giulia Enders include:1. The intricate workings of the digestive system, from the mouth to the colon.2. The impact of diet, stress, and other factors on gut health.3. The role of the gut microbiome in overall health and wellbeing.4. The connection between gut health and various chronic illnesses, such as obesity and autoimmune diseases.5. The importance of maintaining a healthy gut through proper nutrition, exercise, and stress management.Character development in "Gut" primarily focuses on the author, Giulia Enders, as she shares her personal journey of discovering the importance of gut health and how it influenced her own health and wellbeing. Enders also introduces various scientific researchers and health professionals who have contributed to the field of gut health, providing a diverse range of perspectives on the topic.Thematic ideas in "Gut" include:1. The interconnected relationship between the gut and the rest of the body.2. The impact of modern lifestyles, such as processed foods and stress, on gut health.3. The power of the gut microbiome in influencing overall health and wellbeing.4. The importance of holistic approaches to health, including addressing gut health as a foundational component.5. The potential for individuals to take control of their health through informed choices and practices that support gut health.Chapter 3:Meet the Writer of GutIn her book Gut, Giulia Enders demonstrates exceptional writing skills through her clear and engaging language style. She artfully utilizes these elements to effectively convey the complex emotions and meanings associated with the gut and its functions.Enders expresses her fascination and curiosity with the gut in a way that resonates with readers, using descriptive language and vivid imagery to paint a picture of the inner workings of the digestive system. Her writing is imbued with a sense of wonder and awe at the intricacies of the gut, inviting readers to share in her enthusiasm for this often overlooked aspect of the human body.Through her careful choice of words and engaging storytelling, Enders effectively communicates the importance of the gut in maintaining overall health and well-being. She conveys the scientific information in a way that is accessible and easy to understand, making complex concepts digestible for readers of all backgrounds.Enders also infuses her writing with humor and wit, adding a lightheartedness to the subject matter that keeps readers engaged and entertained. This playful tone helps to break down barriers and make the information more relatable, allowing readers to connect with the material on a personal level.Overall, Giulia Enders demonstrates a mastery of writing skills and language style in Gut, using these elements to convey the emotions and meanings associated with the gut in a way that is both informative and engaging. Her ability to captivate readers and effectively communicate complex ideas sets her apart as a talented author and science communicator.Chapter 4:Deeper Understanding of GutThe concept of Gut, or intuition, has had a significant impact on literature, culture, and...

This week, Jason is joined by entrepreneur in talent acquisition professional, Colleen Pelly! Colleen is the founder and CEO of the Linchpin Company, a full service people operations group offering custom recruitment and consulting services. Having worked for major brands such as Tesla and Lululemon, she gained experience in full cycle recruitment from entry level to executive level roles in developing and executing training programs. Colleen gives insight to what people don't know about the recruitment industry, how she came up with the idea for Linchpin Co, and the difference between in house and external recruiting. Colleen also reveals the grant application process,  how connections are a key element to successful recruiting, how she keeps track of her mistakes in business, what can give you an edge over other applicants, what a recruitment scorecard is, and so much more.  If you're looking to make passive income, this is a way to do it. You will get 10 percent off your first invoice with the first role that The Linchpin Co places when you go to https://www.thelinchpinco.com/contact and tell them Trading Secrets sent you!  It's an episode you can't afford to miss!  Host: Jason Tartick Co-Host: David Arduin Audio: John Gurney Guest: The Linchpin Co CEO and Founder Colleen Pelly  Stay connected with the Trading Secrets Podcast!  Instagram: @tradingsecretspodcast  Youtube: Trading Secrets Facebook: Join the Group All Access: Free 30-Day Trial  Trading Secrets Steals & Deals! Cort Furniture: Get furniture on your terms with CORT. Rent or Buy furniture that flexes to fit any situation, style and budget and to get 50% off your first month's furniture rental head over to cort.com/podcast

Have you ever wondered how an eating disorder works? How does one develop and eating disorder? What is the connection between trauma and and eating disorder. Listen to Esther Bursztyn and I discuss it here! Esther Bursztyn is a Licensed Clinical Social Worker in private practice in Lakewood, NJ, specializing in the treatment of eating disorders, trauma, emotional dysregulation, and mood disorders. She has trained extensively in the treatment of eating disorders, achieving designation as a Certified Eating Disorders Specialist (CEDS) through the International Association of Eating Disorder Professionals. In addition, she has been intensively trained in Dialectical Behavior Therapy by Behavioral Tech and in Dialectical Behavior Therapy-Prolonged Exposure (DBT-PE) for trauma and DBT for eating disorders. Eating disorders require specialized care, informed by evidence-based research, strong training, and collaboration with other eating disorder professionals. Esther's approach to eating disorder care is based on a Health At Every Size perspective, wherein she helps her clients learn to eat intuitively, improve body image, and reduce focus on weight and size. In addition to her specialties, Esther enjoys working with people who struggle with self-esteem, anxiety, and/or difficulty managing life stressors and changes. Esther fully believes that all of us have the capacity to make tremendous changes in our lives. The treatments she utilizes are treatments that work and can help you move towards a life worth living. _______ Thank you for being here! Your feedback and support means the world to me. Please reach out to me at gila@gilaglassberg.com if you have any feedback or if you'd like to sponsor my next episode. Exciting news! On July 17th at 12:00pm, I will be giving a webinar on Dispelling Dieting Myths. Sign up here: https://gilaglassberg.com/items/dispelling-diet-myths. Stay tuned for my E-cookbook, coming out soon. Check out my website www.gilaglassberg.com for more podcasts, blogs, courses and now free recipes! Remember- it is never too late to stop dieting and finally make peace with food!

Today's guest is Catherine Pilfrey, an I Ching expert,  meditation teacher, and corporate designer who is also the creator behind the I Ching Oracle deck, which we'll talk more about in this episode. I Ching is also known as the book of changes, and according to Catherine, we can also use the I Ching to help us make decisions in our everyday lives. Check out the I Ching Oracle Deck unboxing video: https://youtu.be/ If you liked this episode, check out the previous GRACED podcast episode with Anne Louise Burdett and Chelsea Granger: https://youtu.be/0sUKs-tC4bU ✨__________ What We Talk About: 00:00 Episode Preview 00:23 Opening 00:58 Introduction 02:15 Interview Begins with Catherine Pilfrey! 02:45 Creative Vision Behind the I Ching Oracle Deck 04:32 Making This Deck Accessible to Everyone 06:38 What Exactly is I Ching? 07:46 What Makes Someone a Good Person? 08:32 Bridging the Gap Between Group and Individual Consciousness 10:17 What Led You to Discover Buddhism? 12:22 Facing Family Backlash After Converting to a New Religion 12:45 The Life-Altering Effects of Meditation 14:28 The Evolution of Your Meditation Practice Over the Years 16:08 Advice for Beginners Starting Their Meditation Journey 17:07 AD - Join the Create Your Deck Club https://cydc.mysticmondays.com/ 17:39 How I Ching Can Guide Your Decisions 19:44 The Inner Workings of the I Ching 21:34 Exploring the Symbolism of Each Card Color 22:41 The Journey of Deck Creation 24:24 Deciphering the Complex Metaphors of the I Ching 26:22 Integrating the I Ching Oracle with Other Decks 26:54 What's Your Sun, Moon, and Rising Signs? 27:31 What Advice Would You Give to Your Younger Self? 28:58 How Would You Define Everyday Magic? 30:10 What Are Your Favorite Rituals? 32:02 What Are You Looking Forward to in the Near Future? 32:29 One Card Collective Reading 32:48 Biddy Tarot Episode Reference 35:04 Closing Statements 35:38 End of Episode – Make Sure to Leave a Podcast Review! 36:40 End Screen ✨__________ Check out the Create Your Deck Club: https://cydc.mysticmondays.com/create-your-deck-club ✨__________ Watch the full podcast interview on YouTube:https://youtu.be/PvbguDQZLJE ✨__________ Read the full show notes and transcript on the Grace Duong Blog: https://www.graceduong.com/podcast ✨__________

Join us for an insightful Market Mondays discussion as we tackle some of the most pressing questions in the financial world today. Is the market rigged to stay at an all-time high, or should we brace for a pullback? We'll delve into where the market is headed from here and share our end-of-year targets for the S&P 500 and Nasdaq.We'll also discuss AMD's stock price in the wake of Nvidia's 10:1 split. Is this the best time to buy NVDA, and should we consider selling AMD and TSM from our portfolios? We'll explore whether Nvidia could eventually become the number one company in the world and if it should be added to the Dow.In this segment, we interviewed Wally Adeyero and Rep. Lauren Underwood about the Treasury Department's latest moves. Should we expect a market crash or correction following the presidential election, and how will the market react based on the outcome?We'll also evaluate investment opportunities in companies like Archer and discuss the impact of SpaceX on Tesla, comparing which of the two might be a better investment. Additionally, we'll identify the three most overhyped sectors in investing right now: EV, biopharma, and weed stocks.In our "Dead or Alive" segment, we analyze the prospects of companies like KLAC, KO, Ralph Lauren, TPR, FSLR, EOG, CNC, and INCY. Lastly, we'll consider whether Trump genuinely believes in crypto after his previous criticisms and discuss the implications of delaying the retirement age to maximize Social Security benefits.#MarketMondays #Investing #StockMarket #Nvidia #AMD #TSM #S&P500 #Nasdaq #Election2024 #Retirement #Crypto #Finance #WealthManagement #SpaceX #Tesla #Archer #OverhypedSectorsOur Sponsors:* Check out Monarch Money: monarchmoney.com/MONDAYSSupport this podcast at — https://redcircle.com/marketmondays/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Behind the scenes at Grant's with Jim, Evan and Phil.

Ralph Burns and John Moran are going over past episodes where John was a guest on the show. What was working then vs. what works now. Join them as they peel back the layers of the digital marketing onion, exploring the seismic shifts in strategy since those older episodes. This isn't just another tech talk—it's a spirited dive into the future of marketing, challenging preconceptions and offering advice you can use right now. Tune in to sharpen your digital prowess and perhaps, change the way you think about your next move in this fast-evolving landscape.Chapters:00:00:00 The John Moran Timeline: Tracing His Ascension in Digital Marketing00:04:02 Inside the Toolbox: Unpacking Performance Max's Utility00:07:51 How Google's Performance Max Scales the Unscalable00:09:12 The Inner Workings of Performance Max: Tactics for Today's Marketers00:11:34 Advanced Strategies: Optimizing Performance Max for Maximum Impact00:13:58 Case Study Insights: Real Results from Implementing Performance Max00:17:01 Performance Max Case Study Breakdown00:21:33 Why Talking Across Platforms is Key to Marketing Success00:24:53 Charting the Maze: Today's Marketing Strategy Complexities00:26:17 The Wild West of Paid Traffic: Unraveling the Chaos00:29:13 Ground Zero: Marketing Insights from the Field00:32:42 Data-Driven Strategies: Making Metrics Work for You00:37:46 Why Historical Data is the Marketer's Crystal Ball00:40:22 Sign-Off: Reflections and What's Next on Perpetual TrafficLINKS AND RESOURCES:PT on TelegramSearch for John MoranTier 11 JobsPerpetual Traffic on YouTubeTiereleven.comSolutions 8 Perpetual Traffic SurveyPerpetual Traffic WebsiteFollow Perpetual Traffic on TwitterConnect with Kasim on Twitter and Connect with Ralph on LinkedInThanks so much for joining us this week. Want to subscribe to Perpetual Traffic? Have some feedback you'd like to share? Connect with us on iTunes and leave us a review!Mentioned in this episode:New Ecommerce Strategies Webinar

We're thrilled to bring you the 17th volume of Finding Mastery's Ask Me Anything (AMA) series. This edition dives deep into the essence of motivation, leadership, and the art of creating a positive work environment, all while emphasizing the crucial importance of self-understanding and authenticity.Joining us - as always - is our insightful co-host, O'Neil Cespedes, ready to unravel another set of thought-provoking topics and questions… In today's conversation, we explore:The inner workings of motivation How to foster environments of growth through competence, autonomy, and relationships.The nuanced art of leadershipThe power of optimism and how to train it in the face of adversityNavigating the delicate balance between image and individualityFacing your own fakeness without shameAnd so much more…Our hope is that this dialogue is more than just an exchange of ideas; that it can create some unlocks, inspiration, and guideposts for those looking to lead with integrity, embrace their true selves, and lean into a life of exploring potential and flourishing.With Fire,MG-----WATCH this episode on our YouTube channel.Connect with us on our Instagram.Order my book, "The First Rule of Mastery" HERE!For more information and shownotes from every episode, head to findingmastery.com.To check out our exclusive sponsor deals and discounts CLICK HERESee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.